Yellow fever SDV 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTKZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,368
Award facts
- Contract value 100% obligated
- $16,368.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,368.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 7, 2026, with an ultimate completion date of January 28, 2026, procures Yellow Fever SDV 5S vaccine products without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform this work at its Park Ridge facility and deliver the products to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. This contract positions DMS Pharmaceutical Group as a critical pharmaceutical supplier within the Department of Defense's global healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FBTKZ?
SPE2DR26FBTKZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FBTKZ worth?
The government has obligated $16,368 on SPE2DR26FBTKZ.
Is contract SPE2DR26FBTKZ an order under another contract?
Yes. SPE2DR26FBTKZ is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTKZ competed?
The extent of competition for SPE2DR26FBTKZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award